To confirm the expression of CCL5/CCR5 signaling axis, we performed immunohistochemistry (IHC) on a total of 8 tissue sections of GB patients, of which 4 are shown along with two non-cancer brain sections (NB1 and NB2) in Figure 1. Here, CCL5 is linked to cancer.